MiraeAsset Leverage US Pharma TOP3 ETN

520079·Stock-Sector-Healthcare

Introduction

This ETN invests in 2x leveraged positions in the top 3 U.S.-listed large pharmaceutical companies by market capitalization.

Benchmark Index

Bloomberg US Pharma Top 3 EW 2x Daily Leveraged Net Return Index

Benchmark Index Description

The index provides 2x leveraged long exposure to the Underlying Index, taking into account the funding cost with funding percentage of 100%.

Issuer

MIRAE ASSET SECURITIES CO.,LTD.

Brand

미래에셋

Total Fee

0.8

Listing Date

2024-09-20

International Securities Code

KRG520000792

Market Information

Market Capitalization

13,480,000,000KRW

Transaction Amount

2,917,300KRW

Trading Volume

217

Shares Outstanding

1,000,000

13,443.25

52-Week High

20,215KRW

52-Week Low

12,810KRW